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Background: The development of anthelmintic resistance (AR) to macrocyclic lactones in the equine roundworm
Parascaris equorum has resulted in benzimidazoles now being the most widely used substance to control Parascaris
infections. However, over-reliance on one drug class is a risk factor for the development of AR. Consequently,
benzimidazole resistance is widespread in several veterinary parasites, where it is associated with single nucleotide
polymorphisms (SNPs) in drug targets encoded by the β-tubulin genes. The importance of these SNPs varies
between different parasitic nematodes, but it has been hypothesised that they occur, at low allele frequencies, even
in unselected populations. This study investigated whether these SNPs exist in the P. equorum population and
tested the hypothesis that BZ resistance can develop from pre-existing SNPs in codons 167, 198 and 200 of the
β-tubulin isotype 1 and 2 genes, reported to be associated with AR in strongylids. The efficacy of the oral paste
formula fenbendazole on 11 farms in Sweden was also assessed.
Methods: Two isotype-specific primer pairs were designed, one on either side of the codon 167 and one on either
side of codons 198 and 200. A pool of 100 000 larvae was sequenced using deep amplicon sequencing by Illumina
HiSeq. Faecal egg count reduction test was used to assess the efficacy of fenbendazole.
Results: No SNPs were observed in codons 167, 198 or 200 of the β-tubulin isotype 1 or 2 genes of P. equorum,
even though 100 000 larvae were sequenced. Faecal egg count reduction testing of fenbendazole showed that this
anthelmintic was still 100% effective, meaning that the likelihood of finding high allele frequency of SNPs associated
with benzimidazoles resistance in P. equorum was low. Unexpectedly, the allele frequencies observed in single
worms were comparable to those in pooled samples.
Conclusions: We concluded that fenbendazole does not exert selection pressure on the β-tubulin genes of
isotypes 1 and 2 in P. equorum. The fact that no pre-existing SNPs were found in codons 167, 198 and 200 in
P. equorum also illustrates the difficulties in generalising about AR mechanisms between different taxonomic
groups of nematodes.
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Parascaris equorum is a nematode parasite of foals and
yearlings with a global distribution. It has a direct life
cycle and is one of the most important equine parasites
because of its high prevalence and severe pathogenicity
[1]. For many years, this ascarid roundworm could be
controlled by strategic use of different anthelmintics, in-
cluding macrocyclic lactones (ML), benzimidazoles (BZ)
and tetrahydropyrimidines (TH) [2]. However, since the
ML ivermectin (IVM) was first introduced in the begin-
ning of the 1980s many horses have been dewormed
with this compound up to six times during their first
year, which has resulted in the development of ML re-
sistance in the P. equorum population [3]. Furthermore,
reduced efficacy of the TH pyrantel pamoate (PYR) in
ML-resistant P. equorum isolates has been reported in
the U.S. [4,5]. In contrast, the BZs fenbendazole (FBZ)
and oxibendazole (OBZ) are still effective and is the an-
thelmintic drug class currently recommended for treat-
ment of P. equorum infection [6].
It has been shown repeatedly that overuse of any an-
thelmintic can lead to selection of resistance-associated
alleles, as experienced for different intestinal nematode
parasites of livestock and horses [1]. For BZ, it is gener-
ally accepted that certain single nucleotide mutations
(SNP) induce changes in amino acids, which may lead to
structural changes in the drug target [1,3]. For many
nematodes of veterinary interest, in particular Hae-
monchus contortus of sheep, BZ resistance has been as-
sociated with SNPs in the β-tubulin isotype 1 molecule,
leading to reduced binding of BZ and thereby loss of an-
thelmintic efficacy [7]. In H. contortus, three different
SNPs have been reported to be responsible for BZ resist-
ance: substitution of phenylalanine (TTC) by a tyrosine
(TAC) at (1) codon 200 [8-11] or at (2) codon 167, also
leading to a shift from TTC by TAC at codon 200 [12],
or (3) a change in glutamate (GAA) to alanine (GCA) at
codon 198 [13]. Homozygous resistance mutations at
more than one locus have never been found, which sug-
gests that single mutations in the β-tubulin gene are tol-
erated, whereas two or more mutations make the
protein dysfunctional and are lethal for the parasite [14].
The mechanisms of AR development in nematodes es-
sentially remain unknown, but it is understood that AR
can arise in three different ways [15,16]. Mutations in
drug targets may appear spontaneously and can then
spread within the parasite populations through gene
flow, for example together with trade of livestock [17].
Thus mutations occur randomly and at a rate, which de-
pends on the reproduction rate and the population size
of the organism [7]. Whether the mutations are then
maintained in the population depends on balancing se-
lection [15]. For example, pre-existing polymorphisms in
the parasite population could be equally selected byunilateral drug treatment, resulting in a rapid increase in
the frequency of resistant alleles. The origin of BZ resis-
tance in equine nematodes is generally unknown, but
the presence of a TAC mutation in codon 167 has been
reported in cyathostomins, even in those from horses
that have never received any anthelmintic treatment
[18]. Whether this indicates that TAC polymorphism
was pre-existing or occurred as a result of gene flow
from another population exposed to BZ is unclear [18].
Similar data on the role of β-tubulin and the deve-
lopment of BZ resistance in other equine nematodes
such as P. equorum are lacking.
There are currently no studies reporting BZ resistance
in P. equorum, but over-reliance on one drug class (in
this case BZ) is regarded as a risk factor for AR develop-
ment [1]. There is only one anthelmintic (fenbendazole)
currently available which is still effective against P.
equorum in Sweden. Therefore drug rotation is not pos-
sible, leading to an increased risk of selection of BZ re-
sistance. The first objective of the present study was
thus to test the hypothesis that BZ resistance in
P. equorum can develop from pre-existing SNPs in co-
dons 167, 198 and 200. This was investigated using the
Illumina HiSeq next generation sequencing (NGS) tech-
nique on a pool of 100 000 eggs from both pre-selected
and unselected isolates of the parasite obtained from
Sweden and the U.S. The second objective was to
examine the anthelmintic efficacy of oral paste formula
fenbendazole (FBZ) on farms in Sweden, as currently
recommended for treatment of P. equorum in foals
(http://www.sva.se/).Methods
For an overview of the experimental design, see Figure 1.Parasite material
Eggs were collected in October-December from the 11
Swedish farms included in the FECRT. Most foals were
about 6–8 months and had been treated with both IVM
and FBZ according to the deworming recommendations
issued by the Swedish Veterinary Institute. Furthermore,
the U.S. isolate was obtained from a closed research
horse herd maintained at the University of Kentucky
without anthelmintic intervention since 1979 [18], and the
parasites maintained there are therefore anthelmintic-
naïve. The second U.S. isolate (U2) was collected during
routine necropsy at the Veterinary Diagnostic Laboratory,
University of Kentucky. The worms from the U.S. were
preserved in ethanol (70-90%) and sent by airmail to the la-
boratory at the Division of Parasitology, Swedish University
of Agricultural Sciences, Uppsala. Upon arrival, all
worms were stored at −70°C until DNA extraction was
performed.
Figure 1 An overview of the experimental design for the pool of 100,000 L3.
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Parascaris eggs were isolated from foal faecal matter
by sieving with different mesh sizes (1000 μm, 150 μm)
and finally collected in an 80 μm sieve. The eggs were
further cleaned by centrifugal flotation and then di-
luted in tap water and stored in ventilated cell culture
flasks at 7°C.
DNA extraction
Prior to DNA extraction, the eggs were washed with
Milton-2 (sodium hypochlorite 2% (v/v) in sodium
chloride 16.5%) solution at 1500 rpm for 3 minutes and
thereafter washed with cold water several times. To in-
crease the DNA yield, the eggs were incubated at 25°C
for 5 days to develop into third stage larvae (L3). Eggs
developed into L3 were divided into 1000 eggs/eppen-
dorf tube and homogenised in 0.2 mL buffer using a
plastic pestle. Complete crushing of the eggs was con-
firmed by light microscopy. DNA was extracted using
Nucleospin Tissue (Macherey-Nagel, Düren, Germany)
according to the manufacturer´s instructions. The DNA
extraction process described above was also performed
on each individual U.S. worm. The purified DNA was
stored at 4°C until further analysis.Primer design
The Illumina TruSeq DNA library preparation kit used
for preparation of sequencing libraries requires an
amplicon size of minimum 120 bp. To achieve the right
size of amplicon, the intron between the exon containing
the 167 codon and the exon containing the 198 and 200
codons was cloned and sequenced using the Big Dye®
Terminator v3.1 Cycle Sequencing Kit Protocol (Applied
Biosystems), according to the manufacturer’s instruc-
tions. The sequences were determined using a Genetic
Analyser (ABI PRISM® 3100). The intron sequences for
β-tubulin 1 and β-tubulin 2 were edited and analysed
with CLC Main Workbench version 5.6.1. A isotype-
specific primer pair was designed on either side of the
codon 167 and another isotype-specific primer pair on
either side of codons 198 and 200 according to Figure 2.
PCR
To enable even amplification from all individuals in the
pool, a touchdown PCR was carried out under the fol-
lowing conditions: 25 μL reaction volumes containing
5 μL of the DNA pool, 10 mM Tris–HCl pH 8.3, 4 μg
Bovine Serum Albumin (BSA), 50 mM KCl, 2 mM
MgCl2, 0.4 μM of each primer, 0.24 mM dNTP, and 1.5
Figure 2 Position of the primers, indicated by arrows and bold font. The codons 167, 198 and 200 are marked in red. Capital letters indicate
the exons and lowercase letters indicate the sequenced intron between the two exons.
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from Applied Biosystems apart from BSA, which was
supplied by New England Biolabs. The touchdown cycling
parameters for the amplification consisted of an initial de-
naturation at 95°C for 5 min, followed by 10 cycles of
95°C for 30 sec, primer annealing at 60–50°C for 30 sec
with an decrease of 1°C/cycle, and extension at 72°C for
1 min, followed by another 20 cycles for 95°C for 30 sec,
primer annealing at 50°C and extension at 72°C for
1 min, with a prolongation of the final extension of
5 min (Bio-Rad, My CyclerTM thermal cycler). After
PCR, amplicons (a pool of 1000) were analysed by elec-
trophoresis on Tris-Borate electrophoresis buffer (TBE)
1.5% agarose gels. Negative water controls were in-
cluded in all runs. Later, the amplicons were pooled to
contain 100,000 individuals and thereafter purified
using Qiaquick (Qiagen). PCR amplification of the pool
of 30 adult worms was performed as described above.
As a check of the methodology, PCR amplification for
one individual adult worm was run in parallel. Prior to
Illumina sequencing, the 100,000 samples were quanti-
fied on Victor (Wallac 1420 VICTOR2TM, software ver-
sion 2.0) using PicoGreen ds DNA quantification kit
(Molecular Probes) and diluted to 14 ng/μL in a total
volume of 50 μL.
Amplicon library preparation for Illumina
Illumina HiSeq compatible sequencing libraries were
prepared using the TruSeq DNA Sample Preparation Kitv2 (Illumina) according to the manufacturer’s instruc-
tions, with the exception that the PCR products were
used directly without a fragmentation step and no size
selection was done before library amplification. The se-
quencing libraries were constructed with individual bar-
codes and all libraries were pooled and sequenced in a
single lane on an Illumina HiSeq2000.
Data analysis
Each amplicon was sequenced to a minimum of 480
Mbp over Q30, yielding a coverage of at least of one mil-
lion X per amplicon. The raw reads were aligned to their
corresponding amplicon using bwa 0.6.2 (bwa aln with -q5
and bwa sampe with standard parameters) [19]. A custom
tool to extract the codons of interest from each read was
developed on top of the GATK Framework [20]. It was re-
quired that every base in the codon should be of Q30 qual-
ity or higher, otherwise the whole read was excluded from
the analysis. Codon frequency was then determined as the
fraction of the codon compared with the total number of
codons observed.
Faecal egg count reduction test
A total of 110 foals, 10 foals/farm, bred and housed on
11 large stud farms in Sweden, were included in the fae-
cal count reduction test (FECRT). The study took place
in autumn 2011, after weaning. The mean age of the
foals was 6.5 months, and they had been dewormed 2 or
3 times during the summer prior to the study. In the









Individual worm 98.0 98.1 97.3
L3 pool 98.3 98.1 97.4
U.S. pool 98.1 98.1 97.3
Table 3 Results of Faecal Egg Count Reduction (FECR) test
evaluating the efficacy of fenbendazole paste (7.5 mg/kg)










Boden 3070 0 7450 100%
Borlänge 140 0 450 100%
Heby 1580 0 3250 100%
Bro 55 0 200 100%
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the standard dose rate of 7.5 mg/kg body weight (Axi-
lur®vet., Intervet Boxmeer, Netherlands). The weight of
the foals was estimated visually by an experienced
horse manager and rounded up to the nearest 50 kg.
Faecal samples were collected from each foal on the
day of treatment (day 0) and again 14 days post-
treatment (day 14), placed in plastic bags and sent to
the laboratory at the Division of Parasitology, Swedish
University of Agricultural Sciences, Uppsala. Samples
were stored overnight at 8°C before analysis. The num-
ber of ascarid eggs per gram faeces (EPG) was deter-
mined both before and after treatment by a modified
McMaster technique, using saturated salt as the
flotation medium (specific gravity 1.2) and with lowest
detection level 50 EPG [21]. Calculations of the effi-
cacy of the FBZ were performed with the FECRT
according to the formula: 1-(mean EPGday0/mean
EPGday14) × 100%. Reductions were calculated using
the arithmetic mean for each farm. Since there is no
internationally agreed standard for evaluating the
FECRT for P. equorum, an isolate was considered re-
sistant when the observed reduction was ≤90% and the
lower confidence limit was ≤90%, and if only one cri-
terion was met AR was suspected. This is in accord-
ance with thresholds used for other equine nematode
parasites and suggestions by [1].
Results
β-tubulin allele frequencies in codons 167, 198 and 200
The allele frequencies in a Parascaris L3 larval pool, a
U.S. pool and individual worms were compared. No
SNPs associated with BZ resistance were observed in
codons 167, 198 or 200 in the genes of β-tubulin iso-
type 1 (Table 1) or isotype 2 (Table 2). A similar low
allele frequency as reported in the L3 larval pool and
the U.S. pool was also observed in the individual
worms analysed here (Additional file 1: Table S1). As
such a low variation should not be present in indivi-
dual worms it was most likely the result of context-
dependent PCR artefacts.
A consistent difference was observed in the genetic
code of codon 200 between isotypes 1 and 2, with









Individual worm 98.2 96.3 96.1
L3 pool 98.2 96.0 95.8
U.S. pool 98.2 96.1 95.8difference had no impact on resistance, because TTC
and TTT both code for the amino acid phenylalanine.
FECRT
Mean efficacy of the oral paste formula FBZ in reducing
P. equorum EPG was tested in foals on 11 stud farms in
Sweden. The FECRT showed 100% efficacy in reducing
EPG on all farms (Table 3).
Discussion
With the emergence of ML resistance, FBZ (a BZ) is
the recommended drug for treatment of P. equorum
infection in foals in Sweden. The results from the
FECRT of FBZ on Swedish farms showed that no eggs
appeared in the faeces 14 days post-treatment and this
anthelmintic was still 100% effective. There are no
previous reports of BZ resistance in P. equorum, pos-
sibly because the use of BZ has been restricted for
therapeutic applications due to the widespread BZ
resistance in cyathostomins since the mid-1970s [2].Ekerö 950 0 2500 100%
Tystberga 100 0 550 100%
Västervik 275 0 500 100%
Västervik 950 0 1250 100%
Landskrona 250 0 550 100%
Svenljunga 1070 0 2200 100%
Sjöbo 970 0 1150 100%
Most foals had a previous history of two treatments of FBZ and IVM prior to
collection of Parascaris equorum eggs.
*EPG, eggs per gram faeces, **FECR = (1-(EPGd14/EPGd0)) × 100%.
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widespread ML resistance, over-reliance on BZ must be
considered an important risk factor that can lead to the
emergence of multiple AR in P. equorum.
Based on SNPs in codon 200 in other nematodes of
veterinary interest, BZ resistance is likely to be a reces-
sive trait [9]. Therefore in light of the results from the
FECRT, there was little likelihood of finding high allele
frequencies of SNPs associated with BZ resistance,
particularly not in the unselected pool of P. equorum.
A total of 100,000 eggs developed to L3 stage were
sequenced, but no variation was observed in codons
167, 198 or 200 in β-tubulin isotypes 1 or 2. Although
the origin of BZ resistance in nematodes is unknown,
it has been hypothesised that resistant alleles already
exist within the parasite population, even prior to drug
selection [10]. Furthermore, in cyathostomins the pres-
ence of TAC mutation in codon 167 is reported to
occur in parasites recovered from horses that have
never received anthelmintic treatment [22]. Similar
findings have been made for the whipworm Trichuris
trichiura, with the presence of TAC mutation in codon
200 having been identified in the population of Haiti
prior to albendazole (ABZ) treatment, and in an ABZ-
naïve T. trichiura isolate from humans in Kenya
[23,24]. No such pre-existing genetic variation in co-
dons 167, 198 or 200 was observed in the P. equorum
isolates studied here. Phylogenetic analysis of currently
known isotypes has shown that representatives of the
Nematoda exhibit more/greater diversity among the β-
tubulin genes than representatives of the Vertebrata
[25]. Based on that observation, it can be stated that
associations of genetic data with BZ resistance cannot
be generalised from one taxonomic group to another.
This statement is further supported by the results
obtained in the present study. Overall, the lack of
BZ-associated SNPs in the P. equorum population
observed in this study, but also in the related ascarid
Ascaris lumbricoides [23], Trichurus spp. [26] and
several strongylids such as Trichostrongylus tenuis
[27], Necator americanus, Ancylostoma duodenale and
A. caninum [28], confirms the need for caution when
generalising about BZ resistance between different
nematodes.
Recent studies in H. contortus have revealed associa-
tions between the selection for ML resistance and the
BZ-associated SNPs in the β-tubulin gene [29]. This
suggests that ML resistance could appear as a result of
selection for BZ resistance [29]. However, although the
Parascaris pool screened for SNPs in this study was
collected from several farms with documented ML re-
sistance [30,31], there was no evidence of a similar
mechanism in Parascaris. In contrast to H. contortus,
it appears that ML resistance does not select for theBZ-associated SNPs in the β-tubulin genes of P.
equorum. This further confirms that generalisations
cannot be made regarding the mechanisms for se-
lection of resistance between different species of
nematodes.
A most important finding was the difference between
the nucleotides in codon 200 in isotype 1 (TTC) and iso-
type 2 (TTT). This codon can thus be used to distin-
guish isotype 1 from isotype 2, but it has no other
impact because both TTC and TTT code for the same
amino acid, phenylalanine.
Next generation sequencing (NGS) is a novel tech-
nique for mass screening of SNPs in pooled samples,
since it permits rapid, deep sequencing of hundreds to
thousands of DNA samples. This range of analysis is
essential for uncovering the full spectrum of genetic
variants occurring at low allele frequencies [32]. Ac-
cordingly, NGS is envisioned to be applied in various
clinical applications, where quantitative screening of
SNPs is important [33]. To date, routine molecular
diagnostic testing for BZ resistance in nematode para-
sites of veterinary importance has mainly been based
on pyrosequencing [22,34]. NGS has multiple advan-
tages over conventional cloning or the single genome
sequencing techniques used for semi-quantification of
rare genetic variants because of its faster speed and
greater depth of coverage [35]. Based on the results
obtained for individual worms sequenced by NGS in
parallel to the pools, we were able to conclude that er-
rors introduced by PCR artefacts were more important
for the detection limit than the current sequencing ac-
curacy. Overall, the results from this study show that
deep sequencing of amplicons with NGS provides the
power to detect rare alleles when screening a large
sample pool.
Conclusions
Reliance on one drug class poses a threat of multiple
AR developing in P. equorum, especially in light of re-
cent findings on the genetic homogeneity of the global
Parascaris population and the high gene flow within
this population [36]. In the present study, a candidate
drive approach was used to screen for SNPs known to
confer BZ resistance. Despite the increased use of BZ
for treatment of Parascaris infection, SNPs in the β-
tubulin genes known to confer resistance in other
nematodes were clearly absent in P. equorum. In stud-
ies seeking new potential markers for resistance, a
non-candidate driven approach would be an option for
determining how AR arise. New potential markers for
AR could hopefully be identified for the taxonomic
group Ascaridoidea by the use of genome-wide
expression profiles before and after exposure of P.
equorum to anthelmintics.
Tydén et al. Parasites & Vectors 2014, 7:410 Page 7 of 8
http://www.parasitesandvectors.com/content/7/1/410Additional files
Additional file 1: Table S1. Allele frequency in codons 167, 198 and
200 of isotope 1 and 2.
Abbreviation
ABZ: Albendazole; AR: Anthelmintic resistance; BZ: Benzimidazoles; EPG: Eggs
per gram faeces; FECRT: Faecal egg count reduction testing;
FBZ: Fenbendazole; ML: Macrocyclic lactones; NGS: Next generation
sequencing; OBZ: Oxibendazole; SNPs: Single nucleotide polymorphisms.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
Conceived and designed the experiments: ET, JH. Performed the
experiments: ET, JD, OK. Analysed the data: ET, JH, JD, OK. Contributed
reagents/materials/analysis tools: ET, JD, OK. Wrote the manuscript: ET, JH, JD,
OK. All authors read and approved the final version of the manuscript.
Acknowledgments
This study was supported by the Swedish-Norwegian Foundation for Equine
Research. We are grateful to the owners of the stud farms for their participation
in the trial and to Martin Nielsen for sending us worms from the closed research
horse herd at the University of Kentucky. Sequencing was performed by the
SNP&SEQ Technology Platform, Science for Life Laboratory, Uppsala University,
a national infrastructure supported by the Swedish Research Council (VR-RFI)
and the Knut and Alice Wallenberg Foundation.
Author details
1Department of Biomedical Sciences and Veterinary Public Health, Division of
Parasitology, Swedish University of Agricultural Sciences, Uppsala S-750 07,
Sweden. 2Department of Medical Sciences, Molecular Medicine and Science
for Life Laboratory, Uppsala University, Uppsala S-751 44, Sweden.
Received: 16 June 2014 Accepted: 18 August 2014
Published: 29 August 2014
References
1. Kaplan RM: Drug resistance in nematodes of veterinary importance: a
status report. Trends Parasitol 2004, 20:477–481.
2. Reinemeyer CR: Anthelmintic resistance in non-strongylid parasites of
horses. Vet Parasitol 2012, 185:9–15.
3. Coles GC, Jackson F, Pomroy WE, Prichard RK, Von Samson-Himmelstjerna G,
Silvestre A, Taylor MA, Vercruysse J: The detection of anthelmintic
resistance in nematodes of veterinary importance. Vet Parasitol 2006,
136:167–185.
4. Craig TM, Diamond PL, Ferwerda NS, Thompson JA: Evidence of ivermectin
resistance by Parascaris equorum on a Texas horse farm. J Equine Vet Sci
2007, 27:67–71.
5. Lyons ET, Tolliver SC, Ionita M, Collins SS: Evaluation of parasiticidal activity
of fenbendazole, ivermectin, oxibendazole, and pyrantel pamoate in
horse foals with emphasis on ascarids (Parascaris equorum) in field
studies on five farms in Central Kentucky in 2007. Parasitol Res 2008,
103:287–291.
6. Reinemeyer CR: Diagnosis and control of anthelmintic-resistant Parascaris
equorum. Parasit Vectors 2009, 25(2 Suppl 2):S8.
7. Beech RN, Skuce P, Bartley DJ, Martin RJ, Prichard RK, Gilleard JS:
Anthelmintic resistance: markers for resistance, or susceptibility?
Parasitology 2011, 138:160–174.
8. Kwa MSG, Veenstra JG, Roos MH: Benzimidazole resistance in Haemonchus
contortus is correlated with a conserved mutation in beta tubulin
isotype 1. Mol Biochem Parasitol 1994, 63:299–303.
9. Elard L, Comes AM, Humbert JF: Sequences of β-tubulin cDNA from
benzimidazole-susceptible and -resistant strains of Teladorsagia
circumcincta, a nematode parasite of small ruminants. Mol Biochem
Parasitol 1996, 79:249–253.
10. Silvestre A, Humbert JF: A molecular tool for species identification and
benzimidazole resistance diagnosis in larval communities of small
ruminant parasites. Exp Parasitol 2000, 95:271–276.11. Schwab AE, Boakye DA, Kyelem D, Prichard RK: Detection of benzimidazole
resistance-associated mutations in the filarial nematode Wuchereria
bancrofti and evidence for selection by albendazole and ivermectin
combination treatment. Am J Trop Med Hyg 2005, 73:234–238.
12. Silvestre A, Cabaret J: Mutation in position 167 of isotype 1 β-tubulin
gene of Trichostrongylid nematodes: role in benzimidazole resistance?
Mol Biochem Parasitol 2002, 120:297–300.
13. Ghisi M, Kaminsky R, Maser P: Phenotyping and genotyping of Haemonchus
contortus isolates reveals a new putative candidate mutation for
benzimidazole resistance in nematodes. Vet Parasitol 2007, 144:313–320.
14. Hodgkinson JE, Clark HJ, Kaplan RM, Lake SL, Matthews JB: The role of
polymorphisms at β tubulin isotype 1 codons 167 and 200 in
benzimidazole resistance in cyathostomins. Int J Parasitol 2008, 38:1149–1160.
15. Gilleard JS, Beech RN: Population genetics of anthelmintic resistance in
parasitic nematodes. Parasitology 2007, 134:1133–1147.
16. Slivestre A, Humbert JF: Diversity of benzimidazole-resistance alleles in
populations of small ruminant parasites. Int J Parasitol 2002, 32:921–928.
17. Blouin MS, Yowell CA, Courtney CH, Dame JB: Host movement and the
genetic structure of populations of parasitic nematodes. Genetics 1995,
141:1007–1014.
18. Lyons ET, Tolliver SC, Collins SS, Drudge JH, Granstrom DE: Transmission of
some species of internal parasites in horses born in 1993, 1994, and
1995 on the same pasture on a farm in Central Kentucky. Vet Parasitol
1997, 70:225–240.
19. Li H, Durbin R: Fast and accurate short read alignment with
Burrows-Wheeler Transform. Bioinformatics 2009, 25:1754–1760.
20. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A,
Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA: The Genome
Analysis Toolkit: a MapReduce framework for analyzing next-generation
DNA sequencing data. Genome Res 2010, 20:1297–1303.
21. Anonymous: Manual of Veterinary Parasitological Laboratory Techniques.
London: Ministry of Agriculture Fisheries and Food; 1986:24.
22. Blackhall WJ, Kuzmina T, Von Samson-Himmelstjerna G: β-Tubulin
genotypes in six species of cyathostomins from anthelmintic-naive
Przewalski and benzimidazole-resistant brood horses in Ukraine.
Parasitol Res 2011, 109:1199–1203.
23. Diawara A, Drake LJ, Suswillo RR, Kihara J, Bundy DA, Scott ME,
Halpenny C, Stothard JR, Prichard RK: Assays to detect beta-tubulin
codon 200 polymorphism in Trichuris trichiura and Ascaris
lumbricoides. PLoS Negl Trop Dis 2009, 3:e397.
24. Diawara A, Halpenny CM, Churcher TS, Mwandawiro C, Kihara J,
Kaplan RM, Streit TG, Idaghdour Y, Scott ME, Basáñez MG, Prichard RK:
Association between response to albendazole treatment and
β-tubulin genotype frequencies in soil-transmitted helminths.
PLoS Negl Trop Dis 2013, 30:e2247.
25. Tydén E, Engström A, Morrison DA, Höglund J: Sequencing of the
β-tubulin genes in the ascarid nematodes Parascaris equorum and
Ascaridia galli. Mol Biochem Parasitol 2013, 190:38–43.
26. Hansen TVA, Nejsum P, Olsen A, Thamsborg SM: Genetic variation in
codons 167, 198 and 200 of the beta-tubulin gene in whipworms
(Trichuris spp.) from a range of domestic animals and wildlife.
Vet Parasitol 2013, 193:141–149.
27. Webster LM, Johnson PC, Adam A, Mable BK, Keller LF: Absence of three
known benzimidazole resistance mutations in Trichostrongylus tenuis, a
nematode parasite of avian hosts. Vet Parasitol 2008, 158:302–310.
28. Schwenkenbecher JM, Albonico M, Bickle Q, Kaplan RM: Characterization
of beta-tubulin genes in hookworms and investigation of resistance-
associated mutations using real-time PCR. Mol Biochem Parasitol 2007,
156:167–174.
29. De Lourdes MM, Prichard RK: Genetic analysis of relationship between
macrocyclic lactone and benzimidazole anthelmintic selection on
Haemonchus contortus. Pharmacogenet Genomics 2008, 18:129–140.
30. Lindgren K, Ljungvall Ö, Nilsson O, Ljungström BL, Lindahl C, Höglund J:
Parascaris equorum in foals and in their environment on a Swedish stud
farm, with notes on treatment failure of ivermectin. Vet Parasitol 2008,
151:337–343.
31. Lind EO, Christensson D: Anthelmintic efficacy on Parascaris equorum in
foals on Swedish studs. Acta Vet Scand 2009, 51:45.
32. Niranjan TS, Adamczyk A, Bravo HC, Taub MA, Wheelan SJ, Irizarry R,
Wang T: Effective detection of rare variants in pooled DNA samples
using Cross-pool tailcurve analysis. Genome Biol 2011, 28:R93.
Tydén et al. Parasites & Vectors 2014, 7:410 Page 8 of 8
http://www.parasitesandvectors.com/content/7/1/41033. Grossmann V, Roller A, Klein HU, Weissmann S, Kern W, Haferlach C, Dugas
M, Haferlach T, Schnittger S, Kohlmann A: Robustness of amplicon deep
sequencing underlines its utility in clinical applications. J Mol Diagn 2013,
15:473–484.
34. Von Samson HG, Walsh TK, Donnan AA, Carriere S, Jackson F: Molecular
detection of benzimidazole resisatnce in Haemonchus contortus using
real-time PCR and pyrosequencing. Parasitol 2009, 136:349–358.
35. Tsibris AM, Korber B, Arnaout R, Russ C, Lo CC, Leitner T, Gaschen B, Theiler
J, Paredes R, Su Z, Hughes MD, Gulick RM, Greaves W, Coakley E, Flexner C,
Nusbaum C, Kuritzkes DR: Quantitative Deep Sequencing Reveals
Dynamic HIV-1 Escape and Large Population Shifts during CCR5
Antagonist Therapy In Vivo. Plos One 2009, 25:e5683.
36. Tydén E, Morrison DA, Engström A, Nielsen MK, Eydal M, Höglund J:
Population genetics of Parascaris equorum based on DNA fingerprinting.
J Infect Genet Evol 2013, 13:236–241.
doi:10.1186/1756-3305-7-410
Cite this article as: Tydén et al.: Deep amplicon sequencing of
preselected isolates of Parascaris equorum in β-tubulin codons associated
with benzimidazole resistance in other nematodes. Parasites & Vectors
2014 7:410.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
